Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations for Finished Pharmaceuticals

---
identifier: "/us/fr/02-21735"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations for Finished Pharmaceuticals"
title_number: 0
title_name: "Federal Register"
section_number: "02-21735"
section_name: "Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations for Finished Pharmaceuticals"
positive_law: false
currency: "2002-08-27"
last_updated: "2002-08-27"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-21735"
document_type: "notice"
publication_date: "2002-08-27"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "67 FR 55020"
fr_volume: 67
docket_ids:
  - "Docket No. 02N-0007"
fr_action: "Notice."
---


#  Agency Information Collection Activities; Announcement of OMB Approval; CGMP Regulations for Finished Pharmaceuticals

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing that a collection of information entitled “CGMP Regulations for Finished Pharmaceuticals” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

**FOR FURTHER INFORMATION CONTACT:**

Karen L. Nelson, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1482.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of May 16, 2002 (67 FR 34939), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0139. This approval expires on August 31, 2005. A copy of the supporting statement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets.

Dated:  August 21, 2002.

Margaret M. Dotzel,

Associate Commissioner for Policy.